FABP1 and breast carcinoma: Compared to the healthy controls, the plasma levels of L-FABP were significantly higher among breast cancer patients (7.6 ng/ml (IQR: 5.2–12.1) versus 6.3 ng/ml (IQR: 5.3–8.5, p = 0.008)).